SERA · Sera Prognostics, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-10 | CRITCHFIELD GREGORY C |
Director |
Award↑
Filing footnotes — Class A Common Stock (Direct)
Each share is represented by a restricted stock unit ("RSU") granted pursuant to the issuer's Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These RSUs vest on the earlier of July 10, 2027 or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Class A Common Stock
|
22,426 |
| 2026-07-10 | Phillips Joshua |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the grant date; provided, however, that the stock options shall be fully vested on the earlier of the first anniversary of the grant date or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Stock Option (right to buy)
|
3,477 |
| 2026-07-10 | Lawrence Sandra AJ |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the grant date; provided, however, that the stock options shall be fully vested on the earlier of the first anniversary of the grant date or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Stock Option (right to buy)
|
3,501 |
| 2026-07-10 | Lawrence Sandra AJ |
Director |
Award↑
Filing footnotes — Class A Common Stock (Direct)
Each share is represented by an additional RSU granted by the Board of Directors. These RSUs vest on the earlier of July 10, 2027 or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Class A Common Stock
|
2,276 |
| 2026-07-10 | Capone Mark Christopher |
Director |
Award↑
Filing footnotes — Class A Common Stock (Direct)
Each share is represented by a restricted stock unit ("RSU") granted pursuant to the issuer's Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These RSUs vest in three annual installments beginning with July 10, 2027, subject to the Reporting Person continuing to provide services to the issuer. |
Class A Common Stock
|
42,404 |
| 2026-07-10 | Phillips Joshua |
Director |
Award↑
Filing footnotes — Class A Common Stock (Direct)
Each share is represented by an additional RSU granted by the Board of Directors. These RSUs vest on the earlier of July 10, 2027 or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Class A Common Stock
|
2,260 |
| 2026-07-10 | Barlow Jane F |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Consists of stock options granted pursuant to the issuer's Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the grant date; provided, however, that the stock options shall be fully vested on the earlier of the first anniversary of the grant date or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Stock Option (right to buy)
|
34,494 |
| 2026-07-10 | Mirza Mansoor Raza |
Chief Medical Officer |
Award↑
Filing footnotes — Class A Common Stock (Direct)
Each share is represented by a restricted stock unit ("RSU") granted pursuant to the issuer's Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These RSUs vest on the earlier of July 10, 2027 or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Class A Common Stock
|
22,426 |
| 2026-07-10 | CRITCHFIELD GREGORY C |
Director |
Award↑
Filing footnotes — Class A Common Stock (Direct)
Each share is represented by an additional RSU granted by the Board of Directors. These RSUs vest on the earlier of July 10, 2027 or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Class A Common Stock
|
1,594 |
| 2026-07-10 | Capone Mark Christopher |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the grant date; provided, however, that the stock options shall be fully vested on the earlier of the first anniversary of the grant date or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Stock Option (right to buy)
|
3,037 |
| 2026-07-10 | Mirza Mansoor Raza |
Chief Medical Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Consists of stock options granted pursuant to the issuer's Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the grant date; provided, however, that the stock options shall be fully vested on the earlier of the first anniversary of the grant date or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Stock Option (right to buy)
|
34,494 |
| 2026-07-10 | Mirza Mansoor Raza |
Chief Medical Officer |
Award↑
Filing footnotes — Class A Common Stock (Direct)
Each share is represented by an additional RSU granted by the Board of Directors. These RSUs vest on the earlier of July 10, 2027 or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Class A Common Stock
|
1,771 |
| 2026-07-10 | Barlow Jane F |
Director |
Award↑
Filing footnotes — Class A Common Stock (Direct)
Each share is represented by a restricted stock unit ("RSU") granted pursuant to the issuer's Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These RSUs vest on the earlier of July 10, 2027 or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Class A Common Stock
|
22,426 |
| 2026-07-10 | Lawrence Sandra AJ |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Consists of stock options granted pursuant to the issuer's Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the grant date; provided, however, that the stock options shall be fully vested on the earlier of the first anniversary of the grant date or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Stock Option (right to buy)
|
34,494 |
| 2026-07-10 | Capone Mark Christopher |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Consists of stock options granted pursuant to the issuer's Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over three years as follows: 1/36 of the original grant amount vests in monthly installments for three years following the grant date, subject to the Reporting Person continuing to provide services to the issuer. |
Stock Option (right to buy)
|
62,766 |
| 2026-07-10 | Capone Mark Christopher |
Director |
Award↑
Filing footnotes — Class A Common Stock (Direct)
Each share is represented by an additional RSU granted by the Board of Directors. These RSUs vest on the earlier of July 10, 2027 or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Class A Common Stock
|
1,975 |
| 2026-07-10 | Kamdar Kim P. |
Director |
Award↑
Filing footnotes — Class A Common Stock (Direct)
Each share is represented by a restricted stock unit ("RSU") granted pursuant to the issuer's Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These RSUs vest on the earlier of July 10, 2027 or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Class A Common Stock
|
22,426 |
| 2026-07-10 | CRITCHFIELD GREGORY C |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Consists of stock options granted pursuant to the issuer's Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the grant date; provided, however, that the stock options shall be fully vested on the earlier of the first anniversary of the grant date or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Stock Option (right to buy)
|
34,494 |
| 2026-07-10 | Mirza Mansoor Raza |
Chief Medical Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the grant date; provided, however, that the stock options shall be fully vested on the earlier of the first anniversary of the grant date or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Stock Option (right to buy)
|
2,725 |
| 2026-07-10 | Kamdar Kim P. |
Director |
Award↑
Filing footnotes — Class A Common Stock (Direct)
Each share is represented by an additional RSU granted by the Board of Directors. These RSUs vest on the earlier of July 10, 2027 or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Class A Common Stock
|
3,421 |
| 2026-07-10 | Phillips Joshua |
Director |
Award↑
Filing footnotes — Class A Common Stock (Direct)
Each share is represented by a restricted stock unit ("RSU") granted pursuant to the issuer's Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These RSUs vest on the earlier of July 10, 2027 or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Class A Common Stock
|
22,426 |
| 2026-07-10 | Lawrence Sandra AJ |
Director |
Award↑
Filing footnotes — Class A Common Stock (Direct)
Each share is represented by a restricted stock unit ("RSU") granted pursuant to the issuer's Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These RSUs vest on the earlier of July 10, 2027 or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Class A Common Stock
|
22,426 |
| 2026-07-10 | CRITCHFIELD GREGORY C |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the grant date; provided, however, that the stock options shall be fully vested on the earlier of the first anniversary of the grant date or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Stock Option (right to buy)
|
2,452 |
| 2026-07-10 | Barlow Jane F |
Director |
Award↑
Filing footnotes — Class A Common Stock (Direct)
Each share is represented by an additional RSU granted by the Board of Directors. These RSUs vest on the earlier of July 10, 2027 or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Class A Common Stock
|
1,949 |
| 2026-07-10 | Kamdar Kim P. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the grant date; provided, however, that the stock options shall be fully vested on the earlier of the first anniversary of the grant date or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Stock Option (right to buy)
|
5,263 |
| 2026-07-10 | Phillips Joshua |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Consists of stock options granted pursuant to the issuer's Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the grant date; provided, however, that the stock options shall be fully vested on the earlier of the first anniversary of the grant date or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Stock Option (right to buy)
|
34,494 |
| 2026-07-10 | Barlow Jane F |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the grant date; provided, however, that the stock options shall be fully vested on the earlier of the first anniversary of the grant date or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Stock Option (right to buy)
|
2,998 |
| 2026-07-10 | Kamdar Kim P. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Consists of stock options granted pursuant to the issuer's Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the grant date; provided, however, that the stock options shall be fully vested on the earlier of the first anniversary of the grant date or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Stock Option (right to buy)
|
34,494 |
| 2026-07-01 | Capone Mark Christopher |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-06-11 | Jackson Benjamin |
General Counsel |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $1.87 to $2.12, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade. |
Class A Common Stock
|
2,179 |
| 2026-06-11 | Lindgardt Zhenya |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $1.87 to $2.12, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade. |
Class A Common Stock
|
6,990 |
| 2026-06-11 | Anderson Dyaarl Lee Jr. |
Chief Commercial Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $1.87 to $2.12, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade. |
Class A Common Stock
|
4,739 |
| 2026-06-11 | Aerts Austin |
Chief Financial Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $1.87 to $2.12, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade. |
Class A Common Stock
|
2,037 |
| 2026-06-11 | Inglis Tiffany Eul Davis |
Chief Medical Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $1.87 to $2.12, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade. |
Class A Common Stock
|
362 |
| 2026-06-09 | Lindgardt Zhenya |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $1.96 to $2.21, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade. |
Class A Common Stock
|
20,755 |
| 2026-06-09 | Aerts Austin |
Chief Financial Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $1.96 to $2.21, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade. |
Class A Common Stock
|
5,440 |
| 2026-06-08 | Lawrence Sandra AJ |
Director |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The transaction(s) reported on this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2025. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.23, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. |
Class A Common Stock
|
1,560 |
| 2026-06-04 | Elliott Jeffrey Thomas |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-05-29 | Anderson Dyaarl Lee Jr. |
Chief Commercial Officer |
Award↑
Filing footnotes — Class A Common Stock (Direct)
These shares were purchased pursuant to the Sera Prognostics, Inc. 2021 Employee Stock Purchase Plan ("ESPP"), for the purchase period of December 1, 2025 to May 29, 2026, and were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
Class A Common Stock
|
3,168 |
| 2026-05-29 | Jackson Benjamin |
General Counsel |
Award↑
Filing footnotes — Class A Common Stock (Direct)
These shares were purchased pursuant to the Sera Prognostics, Inc. 2021 Employee Stock Purchase Plan ("ESPP"), for the purchase period of December 1, 2025 to May 29, 2026, and were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
Class A Common Stock
|
5,000 |
| 2026-03-12 | Jackson Benjamin |
General Counsel |
Award↑
Filing footnotes — Class A Common Stock (Direct)
Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over four years as follows: 1/16 of the original grant amount vests in quarterly installments for four years following the vesting commencement date, which is March 10, 2026, subject to the Reporting Person continuing to provide services to the issuer. |
Class A Common Stock
|
44,215 |
| 2026-03-12 | Inglis Tiffany Eul Davis |
Chief Medical Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
These stock options vest over four years as follows: 1/48 of the original grant amount vests in monthly installments for four years following the vesting commencement date, which is March 10, 2026, subject to the Reporting Person continuing to provide services to the issuer. |
Stock Option (right to buy)
|
27,034 |
| 2026-03-12 | Kearney Paul |
Chief Data Officer |
Other↑
|
No Securities Owned
|
0 |
| 2026-03-12 | Anderson Dyaarl Lee Jr. |
Chief Commercial Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
These stock options vest over four years as follows: 1/48 of the original grant amount vests in monthly installments for four years following the vesting commencement date, which is March 10, 2026, subject to the Reporting Person continuing to provide services to the issuer. |
Stock Option (right to buy)
|
19,310 |
| 2026-03-12 | Lindgardt Zhenya |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
These stock options vest over four years as follows: 1/48 of the original grant amount vests in monthly installments for four years following the vesting commencement date, which is March 10, 2026, subject to the Reporting Person continuing to provide services to the issuer. |
Stock Option (right to buy)
|
239,442 |
| 2026-03-12 | Jackson Benjamin |
General Counsel |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
These stock options vest over four years as follows: 1/48 of the original grant amount vests in monthly installments for four years following the vesting commencement date, which is March 10, 2026, subject to the Reporting Person continuing to provide services to the issuer. |
Stock Option (right to buy)
|
68,550 |
| 2026-03-12 | Anderson Dyaarl Lee Jr. |
Chief Commercial Officer |
Award↑
Filing footnotes — Class A Common Stock (Direct)
Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over four years as follows: 1/16 of the original grant amount vests in quarterly installments for four years following the vesting commencement date, which is March 10, 2026, subject to the Reporting Person continuing to provide services to the issuer. |
Class A Common Stock
|
12,455 |
| 2026-03-12 | Inglis Tiffany Eul Davis |
Chief Medical Officer |
Award↑
Filing footnotes — Class A Common Stock (Direct)
Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over four years as follows: 1/16 of the original grant amount vests in quarterly installments for four years following the vesting commencement date, which is March 10, 2026, subject to the Reporting Person continuing to provide services to the issuer. |
Class A Common Stock
|
17,437 |
| 2026-03-12 | Harrison Robert Gardner |
Chief Information Officer |
Other↑
|
No Securities Owned
|
0 |
| 2026-03-12 | Boniface John J. |
Chief Scientific Officer |
Other↑
|
No Securities Owned
|
0 |